{
    "clinical_study": {
        "@rank": "80735", 
        "arm_group": [
            {
                "arm_group_label": "Normal Saline Control Group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Control group will be administered a one hour normal saline inhaled treatment."
            }, 
            {
                "arm_group_label": "Albuterol Trial Group", 
                "arm_group_type": "Active Comparator", 
                "description": "Trial group to be administered one hour treatment of ten milligrams of inhaled albuterol"
            }
        ], 
        "brief_summary": {
            "textblock": "Empirical data from physician observation indicates an increase in serum lactate in acute\n      asthmatic patients being treated with inhaled albuterol therapy.\n\n      It is not clear if this increased serum lactate is in response to a physiological response\n      to the asthmatic process or from the albuterol treatment.\n\n      This study is designed to determine if administration of inhaled albuterol increases serum\n      lactate in healthy subjects."
        }, 
        "brief_title": "The Various Effects of Gaseous Albuterol on Serum Lactate", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Asthma", 
        "condition_browse": {
            "mesh_term": "Asthma"
        }, 
        "detailed_description": {
            "textblock": "Approximately 30 healthy volunteers will be randomized to Albuterol or placebo.  We powered\n      our study to detect a difference of 0.5 mmol/L, but hypothesize that the difference will be\n      greater than 1.0 mmol/L.\n\n      All volunteer subjects will sign a written consent, approved by the Institutional Review\n      Board.  The intended pool of volunteers will be from residents, attendings, and medical\n      students in the hospital.  The consent form will clearly specify that their participation in\n      the study will not impact their academic status or employment.\n\n      The subjects randomized to the Albuterol arm will receive a one hour 10 mg continuous\n      Albuterol nebulizer treatment.  Those randomized to placebo will receive a one-hour saline\n      nebulizer treatment.  The chief pharmacist for the study will randomly assign a number\n      between one and thirty to fifteen Albuterol treatments and fifteen placebo treatments.\n\n      Subjects will be monitored with cardiac monitor and serum lactate levels will be drawn every\n      15 minutes."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years or older\n\n        Exclusion Criteria:\n\n          -  Pregnant\n\n          -  Prisoner\n\n          -  beta agonist allergy\n\n          -  hypokalemia\n\n          -  taking furosemide, insulin, thiazide diuretics, metformin or acetazolamide\n\n          -  coronary artery disease\n\n          -  hyperthyroidism\n\n          -  abnormal heart rhythm\n\n          -  baseline serum lactate level >2.2 mmol/L\n\n          -  baseline heart rate > 120"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02073747", 
            "org_study_id": "EM 2014.01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Normal Saline Control Group", 
                "description": "One hour inhaled normal saline", 
                "intervention_name": "Normal Saline", 
                "intervention_type": "Drug", 
                "other_name": [
                    "NS", 
                    "Saline"
                ]
            }, 
            {
                "arm_group_label": "Albuterol Trial Group", 
                "description": "One hour inhaled ten milligrams of albuterol", 
                "intervention_name": "Albuterol", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Ventilin", 
                    "Proventil"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Albuterol"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Albuterol", 
            "Serum Lactate", 
            "Lactic Acidosis", 
            "Asthma"
        ], 
        "lastchanged_date": "May 29, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Las Vegas", 
                    "country": "United States", 
                    "state": "Nevada", 
                    "zip": "89102"
                }, 
                "name": "University Medical Center of Southern Nevada"
            }, 
            "investigator": [
                {
                    "last_name": "Joshua R Parker, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Nathan Cleveland, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Tony Zitek, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Steven Elsbecker, DO", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Various Effects of Gaseous Albuterol on Serum Lactate", 
        "overall_contact": {
            "email": "joshuarparker@gmail.com", 
            "last_name": "Joshua R Parker, MD", 
            "phone": "(801) 971-2010"
        }, 
        "overall_contact_backup": {
            "email": "wesley.forred@umcsn.com", 
            "last_name": "Wesely J Forred, RN", 
            "phone": "702-224-7124"
        }, 
        "overall_official": {
            "affiliation": "Emergency Medicine Residency Faculty", 
            "last_name": "Joshua R Parker, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of subjects with a change from baseline serum lactate following a one hour albuterol nebulizer treatment.", 
            "safety_issue": "No", 
            "time_frame": "Change in serum lactate from baseline at 15 min, 30 min, 45 min and 1 hour"
        }, 
        "reference": [
            {
                "PMID": "6414303", 
                "citation": "Appel D, Rubenstein R, Schrager K, Williams MH Jr. Lactic acidosis in severe asthma. Am J Med. 1983 Oct;75(4):580-4."
            }, 
            {
                "PMID": "778959", 
                "citation": "Roncoroni AJ, Adrougu\u00e9 HJ, De Obrutsky CW, Marchisio ML, Herrera MR. Metabolic acidosis in status asthmaticus. Respiration. 1976;33(2):85-94."
            }, 
            {
                "PMID": "11348975", 
                "citation": "Manthous CA. Lactic acidosis in status asthmaticus : three cases and review of the literature. Chest. 2001 May;119(5):1599-602. Review."
            }, 
            {
                "PMID": "9187208", 
                "citation": "Maury E, Ioos V, Lepecq B, Guidet B, Offenstadt G. A paradoxical effect of bronchodilators. Chest. 1997 Jun;111(6):1766-7. Review."
            }, 
            {
                "PMID": "17349773", 
                "citation": "Chaulier K, Chalumeau S, Ber CE, Bret M, Rimmel\u00e9 T. [Metabolic acidosis in a context of acute severe asthma]. Ann Fr Anesth Reanim. 2007 Apr;26(4):352-5. Epub 2007 Mar 8. French."
            }, 
            {
                "PMID": "15911945", 
                "citation": "Rodrigo GJ, Rodrigo C. Elevated plasma lactate level associated with high dose inhaled albuterol therapy in acute severe asthma. Emerg Med J. 2005 Jun;22(6):404-8."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02073747"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University Medical Center of Southern Nevada", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Medical Center of Southern Nevada", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}